NCT06357858 2024-07-03
ASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and Neck
Case Comprehensive Cancer Center
Phase 1 Withdrawn
Clinical Trials
1 trialsWithdrawn × Squamous Cell Carcinoma of Head and Neck × decitabine and cedazuridine drug combination × Clear all